ArticleLeukemia & lymphoma2019
Pre-transplant hypomethylating agents do not influence post-transplant survival in myelodysplastic syndrome.
Dipenkumar Modi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
11 papers cite it
this paperpooled itcites it